Answers are grounded in this paper and cite their sources.
Cerebrovascular dysfunction is a pathological hallmark of Alzheimer's disease (AD). Nevertheless, detecting cerebrovascular changes within bulk tissues has limited our ability to characterize proteomic alterations from less abundant cell types.
No takes yet. Share an insight, caveat, or question.
Wojtas et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: